How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer?

Keeping Current
05/12/2025 19 min
How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer?

Listen "How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer?"

Descargar episodio Ver en sitio original

Episode Synopsis

Where do oral selective estrogen receptor degraders (SERDs) fit in the overall landscape of first- and second-line advanced/metastatic breast cancer? Credit available for this activity expires: 12/04/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-oral-serds-changing-management-advanced-hr-positive-2025a1000xkg?ecd=bdc_podcast_libsyn_mscpedu

More episodes of the podcast Keeping Current

Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care 09/12/2025
Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering 04/12/2025
Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm 02/12/2025
Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data 27/11/2025
Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies 25/11/2025
Coexisting Comorbidities: Advancing Holistic Care in COPD 24/11/2025
Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next? 24/11/2025
Latest Advances in mHSPC: An Update From Berlin 2025 20/11/2025
Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC 20/11/2025
Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond 17/11/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA